EP3011035
ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.6.2014EP published:
13.5.2020EP application number:
14738672.6
EPO information:
European Patent Register
Max expiry date:
9.6.2034
Title:
ASSAY FOR QUANTITATIVE EVALUATION OF TARGET SITE CLEAVAGE BY ONE OR MORE CRISPR-CAS GUIDE SEQUENCES
Timeline
Today
10.6.2014EP application
13.5.2020EP Publication
Owner
Name:
The Broad Institute, Inc.Address:
415 Main Street, Cambridge, MA 02142, US
Name:
Massachusetts Institute of TechnologyAddress:
77 Massachusetts Avenue, Cambridge, MA 02139, US
Name:
The Brigham and Women's Hospital, Inc.Address:
75 Francis Street, Boston, MA 02115, US
Inventor
Name:
ZHANG, FengAddress:
Cambrige, MA 02139, US
Name:
EBERT, Benjamin, LevineAddress:
Brookline, MA 02445, US
Name:
HECKL, DirkAddress:
29352 Adelheidsdorf, DE
Priority
Number:
201361836123 PDate:
17.6.2013Country:
US
Number:
201361915397 PDate:
12.12.2013Country:
US
Classification
Categories:
C12N 15/63, C12N 15/10, C40B 40/08, C12N 9/22